Big news on the Vaxart/vaccine front Bros Nation and I am here to kick that knowledge to you. You know what they say, “buy the rumor, sell the news”. I’m kicking it to you in a packaged deal right now. Hot off them presses it is time (well its been time) to load up and get ready for some action. Are you ready? Then hit that like button. Hit that subscribe button if you’re not already part of the team. If you care about anyone other than yourself, hit that share button so this rising tide can raise all boats and let’s get to it. Vaxart in the news.
Central Hub: https://linktr.ee/moneytalksundayz
Support: https://anchor.fm/moneytalksundayz/support
Welcome to Money Talk Sundayz. I think I’m going to shorten that name though for my midweek podcasts. Maybe just Money Talkz. Anyway, it’s your big bro Stevie Bee from the Investment Bros and I want to share with you some bomb information about Vaxart.
Last week I did a segment on Vaxart explaining what the company is, what they do, and so on. If you remember from that video, one of the driving factors for the company’s speculation was their manufacturing of a Covid vaccine pill.
Now who wouldn’t rather take a pill as opposed to a shot in the arm?
Now while the Covid vaccine pill isn’t the only thing this company has in the pipeline, there is a global demand that is driving the hype and the race to be first out with a successful vaccine. Don’t believe me? Compare Moderna, Pfizer, Astrazeneca, and Johnson & Johnson. Which one has the highest value shares right now? Moderna!
First comes with the biggest piece of the pie as long as the quality is there. In the electric car market it’s Tesla.
Now just two weeks ago market analysts were counting VXRT out of the Covid vaccine pill race. They were speculating that the company would not be able to get a viable candidate out to Phase 2 & 3 testing due to rapidly falling infection rate of Covid.
The delta variant said, HODL MY BEER!
Now Covid is spiking globally and threats of another shutdown are looming worldwide. Horrible news for the vulnerable and the ill. You couldn’t ask for better news if you’re Vaxart.
Why?
A press release from the company is making investors bullish on the company’s new orally administered vaccine. The company says its Investigational New Drug application has been cleared by the Food and Drug Administration (FDA). With this new approval, the company will be able to move forward with Phase Two testing of the vaccine going into the second half of 2021.
The tablet vaccine is the only product by the company that utilizes only S-proteins; most of the company’s products use S- and N-proteins. CSO Sean Tucker says the company is pushing this particular vaccine because clinical data suggests the S-only vaccine “produced much higher serum antibodies than the one expressing both S and N proteins.”
Stock prices have already surged in the wake of the news. Trading volume has already surpassed the daily average; over 14.6 million shares of VXRT are trading so far, against the stock’s average volume of 12.7 million.
I’m not a financial advisor. Not by a long shot BUT I know when something good is over the horizon.
Psst! Something great is over the horizon as we speak!
You want to invest in something that has a clear demand and a clear wide market? Jump in now on Vaxart. It is not too late. Invest what you can afford and continue to do so on a regular basis. When this pill comes to market the share price will explode, mark my words.
Again, this was your big bro Stevie Bee from the Investment Bros signing off for Money Talk Sundayz. Let’s get this moolah! The marathon continues Bros Nation. Peace!
